Delivery Order SPE2DE21D0017-SPE2D625F5A2A
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $69,600 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The contract, which runs through August 28, 2025, covers ID NOW flu testing supplies and is classified as a Delivery Order with economic price adjustment provisions. The award was made through open competition with no set-aside designation, and performance will occur in Lockhart, Florida....
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $23,400 on September 5, 2025, for ID NOW Flu testing supplies. This fixed-price contract with economic price adjustment will be performed in Lockhart, Florida and is scheduled for completion by September 12, 2025. The award was issued without a set-aside designation, indicating open competition. The contract is funded by the Defense Logistics Agency Medical Supply Chain, a key...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. specializing in medical diagnostic equipment and testing supplies, was awarded a delivery order valued at $9,360.00 by the Defense Logistics Agency Medical Supply Chain on September 16, 2025, for ID NOW flu tests. The contract is structured as a fixed-price delivery order with economic price adjustment and carries an ultimate completion date of September 23, 2025. This award was made without a set-aside designation,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,624.00 fixed-price delivery order with economic price adjustment on September 18, 2025, for an ID NOW point-of-care clinical analyzer. The contract is scheduled for completion by September 22, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. Funding is provided by the Defense Logistics Agency Medical Supply Chain, a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,360 fixed-price delivery order with economic price adjustment on July 22, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strip A2 Qual Detect Mobile Test delivery order, is scheduled for ultimate completion on July 23, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating full and open...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostics, was awarded a $6,000 fixed-price delivery order for ID NOW COVID-19 virus test kits by the Defense Logistics Agency Medical Supply Chain on September 11, 2025. The delivery order, which has no set-aside designation, indicates open competition and carries an ultimate completion date of September 19, 2025. The performance location is identified as Lockhart, Florida. This award represents a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,360.00 for ID NOW Strip A2 Qual Detect Microlab Test kits on August 22, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and does not include a set-aside designation, indicating competition was conducted on an unrestricted basis. Performance will be completed in Lockhart, Florida, with an ultimate completion date of August 26, 2025....
- The U.S. federal government awarded a $7,200.00 fixed-price delivery order contract with economic price adjustment to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide 4565764771 ! ID NOW FLU medical supplies. The contract, which does not have a set-aside designation, supports the Defense Logistics Agency Troop Support Medical and is set to be completed by September 16, 2024. Abbott Rapid DX North America LLC, a for-profit organization, is a major supplier of...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F5A2ADelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a $1,200 fixed-price delivery order with economic price adjustment from the Defense Logistics Agency Medical Supply Chain on April 28, 2025, for ID NOW flu diagnostic tests. The contract, awarded without set-aside designation through open competition, is designated as delivery order 4568059894 and carries an ultimate completion date of May 5, 2025. Performance will be executed at the contractor's location in Lockhart, Florida. This delivery order represents a continuation of Abbott Rapid DX's established role as a critical supplier of point-of-care diagnostic testing solutions to federal healthcare agencies. The Defense Logistics Agency Medical Supply Chain procures medical diagnostic equipment and testing supplies to support Department of Defense healthcare operations and federal medical facilities. Abbott Rapid DX's contract portfolio with federal agencies demonstrates consistent capability in delivering rapid diagnostic testing products, with this ID NOW flu test award aligning with the company's core business providing advanced diagnostic technologies for federal healthcare testing and surveillance needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/28/25 |